Generic drug: Revision history

2 February 2023

• curprev 13:1713:17, 2 February 2023‎ Pat Palmer talk contribs‎ m 18,248 bytes +55‎ Text replacement - "United States" to "United States of America"

31 March 2011

• curprev 09:3509:35, 31 March 2011‎ imported>Robert Badgett‎ 18,193 bytes +18,193‎ No edit summary

19 January 2011

• curprev 09:0609:06, 19 January 2011‎ imported>Robert Badgett‎ 17,634 bytes +1,272‎ →‎Promotion of generic drugs

9 August 2010

• curprev 20:3620:36, 9 August 2010‎ imported>Robert Badgett‎ 16,617 bytes +182‎ No edit summary

12 July 2010

• curprev 23:4923:49, 12 July 2010‎ imported>Robert Badgett‎ 16,435 bytes +62‎ →‎Establishing bioequivalence

9 October 2009

• curprev 13:0513:05, 9 October 2009‎ imported>Robert Badgett‎ 16,373 bytes +11‎ →‎Authorized generics

30 August 2009

• curprev 15:3615:36, 30 August 2009‎ imported>Robert Badgett‎ m 16,362 bytes +162‎ →‎Abbreviated New Drug Application

18 June 2009

• curprev 15:4115:41, 18 June 2009‎ imported>Robert Badgett‎ 16,200 bytes +5,531‎ →‎United States

2 February 2009

• curprev 20:5720:57, 2 February 2009‎ imported>Robert Badgett‎ m 16,165 bytes −2‎ →‎Promotion of generic drugs
• curprev 20:5620:56, 2 February 2009‎ imported>Robert Badgett‎ 16,167 bytes +520‎ No edit summary
• curprev 20:3720:37, 2 February 2009‎ imported>Robert Badgett‎ 15,647 bytes +5,593‎ →‎Abbreviated New Drug Application and establishing bioequivalence
• curprev 16:3316:33, 2 February 2009‎ imported>Robert Badgett‎ 13,309 bytes −28‎ No edit summary
• curprev 16:3116:31, 2 February 2009‎ imported>Robert Badgett‎ 13,337 bytes +1,235‎ Reorganizing
• curprev 02:1102:11, 2 February 2009‎ imported>Robert Badgett‎ m 13,233 bytes −2‎ No edit summary
• curprev 02:0802:08, 2 February 2009‎ imported>Robert Badgett‎ 13,235 bytes +799‎ No edit summary
• curprev 02:0102:01, 2 February 2009‎ imported>Robert Badgett‎ 12,436 bytes +146‎ →‎Ensuring bioequivalence
• curprev 01:5301:53, 2 February 2009‎ imported>Robert Badgett‎ 12,290 bytes +84‎ →‎External links
• curprev 01:5201:52, 2 February 2009‎ imported>Robert Badgett‎ 12,206 bytes +47‎ →‎External links
• curprev 01:4801:48, 2 February 2009‎ imported>Robert Badgett‎ 12,159 bytes +57‎ →‎Authorized generics
• curprev 01:4601:46, 2 February 2009‎ imported>Robert Badgett‎ 12,102 bytes +1,559‎ →‎180 Day Generic Drug Exclusivity
• curprev 01:3401:34, 2 February 2009‎ imported>Robert Badgett‎ 12,076 bytes +607‎ →‎180 Day Generic Drug Exclusivity
• curprev 01:2601:26, 2 February 2009‎ imported>Robert Badgett‎ 11,469 bytes +926‎ →‎Reasons for cheaper price
• curprev 00:4000:40, 2 February 2009‎ imported>Robert Badgett‎ 11,288 bytes +745‎ No edit summary
• curprev 00:2800:28, 2 February 2009‎ imported>Robert Badgett‎ 10,543 bytes +489‎ →‎180 Day Generic Drug Exclusivity
• curprev 00:2300:23, 2 February 2009‎ imported>Robert Badgett‎ 10,433 bytes −1‎ →‎When can a generic drug be produced?
• curprev 00:2300:23, 2 February 2009‎ imported>Robert Badgett‎ 10,434 bytes +380‎ →‎When can a generic drug be produced?
• curprev 00:2000:20, 2 February 2009‎ imported>Robert Badgett‎ 10,054 bytes −615‎ →‎180 Day Generic Drug Exclusivity

1 February 2009

• curprev 23:5723:57, 1 February 2009‎ imported>Robert Badgett‎ 9,747 bytes −2‎ Reordered sections
• curprev 23:5623:56, 1 February 2009‎ imported>Robert Badgett‎ 9,749 bytes −920‎ Consolidated Further reading and External links
• curprev 23:5323:53, 1 February 2009‎ imported>Robert Badgett‎ 9,832 bytes −837‎ Consolided economic content into one section
• curprev 23:4123:41, 1 February 2009‎ imported>Robert Badgett‎ 10,669 bytes −1,863‎ →‎Reasons for cheaper price: Added image
• curprev 23:3223:32, 1 February 2009‎ imported>Robert Badgett‎ m 10,594 bytes +1‎ →‎Ensuring bioequivalence
• curprev 23:3223:32, 1 February 2009‎ imported>Robert Badgett‎ 10,593 bytes −3,397‎ Moved content to new bioequivalence article
• curprev 23:1823:18, 1 February 2009‎ imported>Robert Badgett‎ 13,990 bytes −236‎ →‎Ensuring bioequivalence: Removed sentences about cost that do not seem to belong here 'Consumers would undoubtedly benefit from more clinical studies done on drug by drug basis. Generic drugs st
• curprev 23:1823:18, 1 February 2009‎ imported>Robert Badgett‎ 14,226 bytes −716‎ →‎Ensuring bioequivalence
• curprev 23:0323:03, 1 February 2009‎ imported>Robert Badgett‎ 14,491 bytes −393‎ →‎Ensuring bioequivalence: Removed text that does not seem to belong here 'Generic drugs are always less expensive and can save patients and insurance companies thousands of dollars supposedly wit
• curprev 22:5822:58, 1 February 2009‎ imported>Robert Badgett‎ 14,884 bytes −58‎ →‎External links: Removed broken links

29 January 2009

• curprev 09:4909:49, 29 January 2009‎ imported>Robert Badgett‎ 14,942 bytes +2,410‎ →‎Ensuring bioequivalence
• curprev 09:4709:47, 29 January 2009‎ imported>Robert Badgett‎ 14,944 bytes +1,032‎ →‎Ensuring bioequivalence
• curprev 09:4009:40, 29 January 2009‎ imported>Robert Badgett‎ 13,912 bytes +1,608‎ →‎Patent lifetime and research cost issues
• curprev 09:3609:36, 29 January 2009‎ imported>Robert Badgett‎ 12,304 bytes −228‎ →‎See also: Removed this section as all links were broken

2 December 2008

• curprev 23:4023:40, 2 December 2008‎ imported>Robert Badgett‎ 12,532 bytes +559‎ →‎Ensuring bioequivalence

3 October 2007

• curprev 08:0308:03, 3 October 2007‎ imported>ZachPruckowski‎ m 11,998 bytes +25‎ →‎Ensuring bioequivalence: fix link

26 September 2007

• curprev 13:5613:56, 26 September 2007‎ imported>Subpagination Bot‎ m 11,973 bytes +11,973‎ Add {{subpages}} and remove any categories (details)

8 April 2007

• curprev 18:3618:36, 8 April 2007‎ imported>Petréa Mitchell‎ m 11,999 bytes −22‎ →‎External links: Big Cleanup

17 March 2007

• curprev 22:2222:22, 17 March 2007‎ imported>Thomas E Kelly‎ 12,021 bytes +39‎ No edit summary

11 February 2007

• curprev 09:1809:18, 11 February 2007‎ imported>Stefan von Berg‎ 11,982 bytes +11,982‎ No edit summary